5 Reasons To Download The Agenda:
Explore In-House Insights: Discover the valuable perspectives from leading companies such as Astellas, UCB, Sandoz, Novartis, Chiesi, Fresenius Kabi, and MSD, delivered directly by our distinguished in-house speaking faculty.
Engage in Targeted Sessions: Dive into the most pressing pharma and biotech patent litigation topics, including preliminary injunctions (PIs), the Unified Patent Court (UPC), competition law, Supplementary Protection Certificates (SPCs), and biosimilars.
- Network with Top Firms: Gain insights from a diverse range of international and boutique patent litigation firms, participating as panellists and speakers, to enhance your understanding of the global litigation landscape.
- Tailor Your Strategy: Benefit from our new and improved tracked sessions on day 2, focusing on MedTech, small molecules, and large molecules, allowing you to craft a more personalized and effective patent litigation strategy.
- Hear from Key Decision-Makers: Learn directly from judicial and institutional speakers providing firsthand updates from critical bodies such as the UPC, UK courts, WIPO, EFPIA, the European Commission, and Medicines for Europe.